The Food and Drug Administration has issued an emergency use authorization for a rapid, single-use test to detect Ebola virus. The test is the second Ebola fingerstick test to receive an EUA, but the first to use a portable battery-operated reader. “By authorizing the first fingerstick test with a portable reader, we hope to better arm health care providers in the field to more quickly detect the virus in patients and improve patient outcomes,” said FDA Commissioner Scott Gottlieb, M.D., noting that the agency continues to collaborate with federal, international and industry partners to assist in the global response to the Ebola outbreak in the Democratic Republic of Congo.
 

Related News Articles

Headline
The Food and Drug Administration yesterday approved the first FDA-approved vaccine to prevent Ebola in adults with Zaire ebolavirus, which killed more…
Headline
The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living…
Headline
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which…
Headline
The World Health Organization recently deployed a rapid response team and personal protective equipment to the United Republic of Tanzania following unofficial…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce…
Headline
Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those…